Analysts forecast that American Vanguard Corp. (NYSE:AVD) will announce $126.70 million in sales for the current quarter, according to Zacks. Two analysts have issued estimates for American Vanguard’s earnings, with estimates ranging from $124.80 million to $128.60 million. American Vanguard reported sales of $107.05 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 18.4%. The company is scheduled to report its next earnings report on Monday, August 5th.

On average, analysts expect that American Vanguard will report full year sales of $514.60 million for the current financial year, with estimates ranging from $509.20 million to $520.00 million. For the next year, analysts expect that the business will post sales of $540.80 million. Zacks’ sales calculations are an average based on a survey of sell-side analysts that that provide coverage for American Vanguard.

American Vanguard (NYSE:AVD) last announced its quarterly earnings results on Tuesday, May 7th. The basic materials company reported $0.13 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.12 by $0.01. American Vanguard had a return on equity of 7.17% and a net margin of 5.21%. The business had revenue of $99.70 million during the quarter, compared to the consensus estimate of $105.20 million. During the same quarter in the prior year, the company posted $0.16 earnings per share. American Vanguard’s revenue was down 4.2% compared to the same quarter last year.

Several research firms have weighed in on AVD. ValuEngine cut Woodward, Inc.Common Stock from a “buy” rating to a “hold” rating in a report on Tuesday, April 9th. Zacks Investment Research upgraded Gerdau from a “sell” rating to a “hold” rating in a report on Monday, May 13th.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. BNP Paribas Arbitrage SA increased its position in American Vanguard by 218.1% during the 1st quarter. BNP Paribas Arbitrage SA now owns 7,325 shares of the basic materials company’s stock valued at $126,000 after buying an additional 5,022 shares in the last quarter. Metropolitan Life Insurance Co. NY increased its position in American Vanguard by 382.8% during the 4th quarter. Metropolitan Life Insurance Co. NY now owns 10,130 shares of the basic materials company’s stock valued at $154,000 after buying an additional 8,032 shares in the last quarter. Oregon Public Employees Retirement Fund bought a new position in American Vanguard during the 4th quarter valued at approximately $154,000. Menta Capital LLC bought a new position in American Vanguard during the 4th quarter valued at approximately $172,000. Finally, Two Sigma Advisers LP increased its position in American Vanguard by 11.4% during the 4th quarter. Two Sigma Advisers LP now owns 11,761 shares of the basic materials company’s stock valued at $179,000 after buying an additional 1,200 shares in the last quarter. Institutional investors own 77.04% of the company’s stock.

NYSE AVD traded up $0.01 during trading on Friday, reaching $14.64. The company’s stock had a trading volume of 102,364 shares, compared to its average volume of 90,664. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.31 and a quick ratio of 1.02. The company has a market capitalization of $435.07 million, a PE ratio of 18.07 and a beta of 1.39. The stock has a fifty day moving average of $14.37. American Vanguard has a one year low of $12.69 and a one year high of $22.20.

The company also recently announced a quarterly dividend, which was paid on Friday, July 12th. Stockholders of record on Friday, June 28th were paid a $0.02 dividend. This represents a $0.08 dividend on an annualized basis and a dividend yield of 0.55%. The ex-dividend date was Thursday, June 27th. American Vanguard’s payout ratio is presently 9.88%.

About American Vanguard

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. The company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.

Recommended Story: How Do Investors Open a Backdoor Roth IRA?

Get a free copy of the Zacks research report on American Vanguard (AVD)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.